Linde plc

NASDAQ:LIN

Chemicals - Specialty

Basic Materials
$512.16 -0.17%

-$0.89 today

Market cap
$235.12B
Beta
0.73
P/E (TTM)
33.5
EPS (TTM)
$15.35
Dividend yield
1.20%
52W Low $387.78High $525.87

Volume 1.37M

Average 2.28M

LIN Accumulated OCI

Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.

Linde plcNASDAQ: LIN

Accumulated OCI · Q2 FY2026 · quarter ended Jun 2026

Accumulated OCI remains negative

Q2 FY2026 Accumulated OCI was -$5.93B, compared with -$6.25B a year earlier.

Context

  • Accumulated OCI amounted to 6.7% of total assets at the end of Q2 FY2026, down 0.6 pp from a year earlier.
  • Accumulated OCI grew in size in 2 of the last 3 fiscal years.

What to watch

Whether Accumulated OCI keeps rising in the next quarterly balance sheet after a +5.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$5.93B+3.6% QoQ
Last fiscal yearDec 2025
-$6.23B+9.6% YoY
Year agoJun 2025
-$6.25B+5.2% since
Accumulated OCI past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+5.2%——
1 year+9.6%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accumulated OCI history

USD · from the balance sheet

Latest · FY2025
(6.23B) USD
Year-over-year change
+9.6%

Accumulated OCI vs competitors

How LIN compares with its peers on the latest reported figures

  • LIN's Jun 2026 Accumulated OCI of -$5.93B is the lowest of the 2 companies compared; the peer median is $0.
  • Its year-over-year change of +5.2% is the lowest of 2, against a peer median of +100.0%.
  • Accumulated OCI amounts to 6.7% of total assets for LIN, versus a peer median of 0.0%.
LIN Competitors Peer median
Accumulated OCI for LIN and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
APDAir Products and Chemicals, Inc.Sep 2026$0 +100.0%—0.0%
LINLinde plcJun 2026-$5.93B +5.2%—6.7%
Peer median (excluding LIN) $0+100.0%—0.0%

Competitors are the stored peer set for LIN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents2.82B5.44B4.66B4.85B5.06B
Short-term Investments00000
Net Receivables4.83B4.91B5.09B5.06B5.24B
Inventory1.73B1.98B2.12B1.95B2.06B
Other Current Assets247M128M166M508M979M
Total Current Assets10.16B13.05B12.62B12.95B13.33B
Property, Plant & Equipment (Net)26B23.55B25.49B25.76B29.34B
Goodwill27.04B25.82B26.75B25.94B27.93B
Intangible Assets13.8B12.42B12.4B11.33B11.87B
Long-term Investments2.64B2.53B2.38B2.24B2.12B
Tax Assets242M230M226M0423M
Other Non-current Assets1.72B2.06B948M1.94B1.81B
Total Non-current Assets71.45B66.61B68.19B67.2B73.49B
Total Assets81.61B79.66B80.81B80.15B86.82B
Account Payables3.5B3B3.02B2.51B2.81B
Short-term Debt2.87B5.72B5.98B6.28B6.31B
Tax Payables724M872M917M00
Deferred Revenue2.94B3.07B1.9B1.19B1.23B
Other Current Liabilities2.89B3.19B3.22B1.27B4.85B
Total Current Liabilities13.64B16.48B15.72B14.54B15.2B
Long-term Debt11.34B12.2B13.4B15.34B20.68B
Deferred Tax Liabilities(7B)05.75B00
Deferred Revenue (Non-current)7B01.05B00
Other Non-current Liabilities10.44B8.94B3.09B10.02B11.2B
Total Non-current Liabilities22.52B21.79B24B26.12B31.88B
Total Liabilities36.16B38.27B39.72B40.66B47.08B
Common Stock1M1M1M1M1M
Retained Earnings18.71B20.54B8.85B12.63B16.61B
Accumulated OCI(5.05B)(5.78B)(5.81B)(6.89B)(6.23B)
Other Stockholders Equity00000
Minority Interest1.41B1.36B1.38B1.4B1.5B
Total Equity45.44B41.39B41.1B39.49B39.74B
Total Debt15.22B18.79B20.32B22.61B26.99B
Net Debt12.39B13.36B15.65B17.76B21.93B

Linde plc

NASDAQ:LIN

Intrinsic Alpha fair value

Locked

Current Price

$512.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.